Lantheus Holdings, Inc. Payments for Repurchase of Initial Public Offering
Lantheus Holdings, Inc. (LNTH) reported Payments for Repurchase of Initial Public Offering of $6.36 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2016-03-02
- Lantheus Holdings, Inc. payments for repurchase of initial public offering for the quarter ending 2015-12-31 was $104.00K.
- Lantheus Holdings, Inc. payments for repurchase of initial public offering for the quarter ending 2015-09-30 was $1.00M.
- Lantheus Holdings, Inc. payments for repurchase of initial public offering for fiscal 2015 was $6.36M.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2015-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02 | $1.11M derived: sum of 2 quarters · filed 2016-03-02 | $6.36M 10-K · filed 2016-03-02 | |
| 2015-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $6.26M 10-Q · filed 2015-11-04 | ||
| 2015-06-30 | $5.25M 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |